Within the next decade I now believe surgical robotic systems will become a standard feature in operating theatres.
All clinical targets were achieved with the system demonstrating surgical activities in the pelvic, upper gastrointestinal (“GI”) and colorectal surgical areas. Procedures were filmed both internally and externally and collected data will inform further cadaveric, animal, and first-in-human trials. Cadaveric trials followed the successful completion of bench tests with full-size simulators.
The trials were held at The Evelyn Cambridge Surgical Training Centre and conducted by CMR’s Medical Director Mark Slack and other members of CMR’s Medical Affairs team.
Mark Slack commented: “The successful completion of preliminary cadaveric trials is a significant milestone in the planned development and regulatory processes. The trials allowed us to demonstrate the advanced capabilities of the CMR system including haptic force feedback, fully wristed 5mm instruments and the ability to perform a wide range of multi-quadrant minimal access procedures including urological, gynaecological, upper GI and colorectal procedures, all with standard port placements making the future transition to robotics as easy as possible for surgeons.
“Within the next decade I now believe surgical robotic systems will become a standard feature in operating theatres and a critical extension of the modern day surgeon. With its small and light weight form factor, ease of set up and versatile design the CMR system is strongly positioned to extend the benefits of minimal access surgery to a greater number of patients.”
Mark Slack is a Consultant Surgeon and the Head of Urogynaecology at Addenbrooke’s Hospital, Cambridge University Hospitals.
About the CMR surgical robotic system
CMR’s modular system uses state-of-the-art 3D high-definition imagery, significantly enhanced flexibility, and force feedback to provide surgeons with life-like sensitivity.
The system overcomes obstacles to widespread adoption of robotic minimal access surgery, namely robot size, instrument size, versatility, port placement, cost and ease of use, allowing the system to be highly utilised and cost-comparable to manual laparoscopic surgery.
About Cambridge Medical Robotics Limited
Cambridge Medical Robotics is a private company developing the next-generation universal robotic system for minimal access (or “keyhole”) surgery.
Our vision is to make minimal access surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically. This will transform the existing market for surgical robotics.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025[1].
Cambridge Medical Robotics was formed in 2014 and has its headquarters in Cambridge, United Kingdom. The company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
For further information please visit: www.cmedrobotics.com
About CMR Surgical
CMR Surgical is a private, British, company developing the next-generation universal robotic system, Versius®, for minimal access (or “keyhole”) surgery.
The vision behind CMR is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics and addressing the six million people who still undergo open surgery each year.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1
CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
For further information, please visit: https://cmrsurgical.com/
*******
Contacts:
CMR Surgical
Martin Frost
Chief Executive Officer
Tel: +44 (0) 1223 755 300
Email: martin.frost@cmedrobotics.com
Consilium Strategic Communications
Mary-Jane Elliott, Ivar Milligan
Tel: +44 20 3709 5700
Email: CMR@consilium-comms.com
___________________________________________________